Tuesday, September 23, 2014

Hot Healthcare Equipment Stocks To Own For 2014

Rio Tinto plc (RIO), a leading name in the mining industry, enhanced its coal output, as the company-operated Kestrel Mine Extension started coal production. The Extension is a $2 billion project in central Queensland.

The mine construction was started in 2008, with the first glimpse of coal in Jul 2011. The extension, Kestrel South, will increase the production capacity of the mine by roughly 20 years. The mine will reach full capacity by 2014, and will be capable of producing roughly 5.7 million tonnes of coal per year, for the next 20 years. A 4.9 miles (7.9 kilometer) conveyor belt has been built with the capacity to carry 3,500 tonnes of coal per hour. It is expected that the mine will have its first shipment in a few weeks.

The strategic location will enable Rio Tinto to utilize its Australian platform and cater to the demand from South Eastern Asian counties like Japan, Korea, Taiwan, China and India.

Rio Tinto�� subsidiaries have achieved a significant milestone this current month. Another subsidiary, Oyu Tolgoi�� copper and gold mine in Mongolia has conducted its first outward shipment. The mine has an annual production capacity of 430,000 tonnes of copper and 425,000 ounces of gold, over the next 20 years.

Top Companies To Own In Right Now: Parametric Technology Corporation(PMTC)

Parametric Technology Corporation develops, markets, and supports product lifecycle management (PLM) software solutions and services that help companies design products, manage product information, and enhance product development processes worldwide. Its PLM solutions comprise Windchill, an Internet-based content and process management solution for managing data and relationships, processes, and publications; Arbortext, an enterprise solution to manage complex information assets that enhance their customer support and service center information delivery processes; Creo View, which enables enterprise-wide visualization, verification, annotation, and automated comparison of various product development data formats; and Integrity that coordinates and manages various activities and artifacts associated with developing software-intensive products. The company?s desktop solutions include Creo Parametric, a family of three-dimensional product design solutions based on a parametr ic, feature-based solid modeler that enables changes made during the design process to be associatively updated throughout the design; Creo Elements/Direct, a family of computer aided design and collaboration software used for customers to meet short design cycles and to create product designs; Mathcad, an engineering calculation software solution, which combines a computational engine, accessed through conventional math notation, and with a full-featured word processor and graphing tools; and Arbortext to help customers improve documentation accuracy, speed time to market, reduce translation requirements, and lower publishing costs. In addition, it provides consulting, implementation, training, maintenance, and computer-based training products. Parametric Technology sells its products and services through direct sales force and third-party resellers and other strategic partners. The company was founded in 1985 and is headquartered in Needham, Massachusetts.

Advisors' Opinion:
  • [By Northrop Puckett]

    The company is facing headwinds in the broader economy. This can be seen in declining sales in many areas of their business. Regionally, the U.S was flat; Northern Europe was up; Southern Europe was down; and emerging markets were down. Autodesk also lowered quarterly and yearly revenue expectations. This lowering of guidance by Autodesk also matches the same guidance changes made by competitors Parametric Technology (PMTC) and ANSYS (ANSS), so it is not necessarily losing out to its rivals in this case.

  • [By Eric Volkman]

    PTC (NASDAQ: PMTC  ) results for the company's Q2 have been released. For the quarter, non-GAAP revenue was just under $315 million, which bettered the $302 million the company posted in the same period the previous year. Net profit also saw an increase, advancing to $49.6 million ($0.41 per diluted share) from Q2 2012's $35.9 million ($0.30).

Hot Healthcare Equipment Stocks To Own For 2014: Intrepid Potash Inc (IPI)

Intrepid Potash, Inc.( Intrepid), incorporated on November 19, 2007, is a producer of muriate of potash (potassium chloride or potash) in the United States and are engaged the production and marketing of potash and langbeinite (sulfate of potash magnesia), another mineral containing potassium, magnesium, and sulfate, that is produced from langbeinite ore and as Trio when it refers to sales and marketing. Its Carlsbad assets consist of underground mining operations, which are supported by surface processing facilities. It is also operators of solar solution mining operations, as its Moab and Wendover facilities both utilize these techniques for recovering potash. Its revenues are generated from the sale of potash and Trio. As of December 31, 2011, the Company owned five potash production facilities, three in New Mexico and two in Utah. Its two products are potash and langbeinite, which is marketed as Trio.

Potash

The Company derives revenues and gross margin are derived from the production and sales of potash. Its potash is marketed for sale into three primary markets: the agricultural market as a fertilizer, the industrial market as a component in drilling and fracturing fluids for oil and gas wells, and the animal feed market as a nutrient. Its sales of potash tend to focus on agricultural areas and feed manufacturers in central and western United States, as well as oil and gas drilling areas in the Rocky Mountains and the greater Permian Basin area.

Trio

Trio is marketed into two primary markets, the agricultural market as a fertilizer and the animal feed market as a nutrient. It markets Trio internationally through an exclusive marketing agreement with PCS Sales (USA), Inc. (PCS Sales) for sales outside the United States and Canada and through a non-exclusive agreement for sales into Mexico.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Gains are being seen elsewhere as well, except in shares of The Mosaic Company (NYSE: MOS). Agrium�Inc. (NYSE: AGU) was up almost 3% at $91.95 in late Monday trading, although this one held up much better in the destructive news phase when the alarming news roiled these stocks. The big winner is Intrepid Potash, Inc. (NYSE: IPI), with a gain of 7% to $16.20 in late-Monday trading.

  • [By Robert Ciura]

    As a result, valuations of industry leaders Potash Corp. (NYSE: POT  ) , The Mosaic Company (NYSE: MOS  ) , and Intrepid Potash (NYSE: IPI  ) have compressed dramatically, leaving each stock looking very cheap on the surface.

  • [By Tim Gallagher]

    Mosaic (MOS), Agrium (AGU), Intrepid Potash (IPI) and CF Industries (CF) have been moving and trading hand-in-hand, with AGU, BHP and Rentech Nitrogen Partners LP (RNF) trading the best, losing the least and rebounding the most since July 30th. IPI has sold off a lot more in the post-news period, as would be expected from a smaller, less established company with mine projects still in development. BHP Billiton Ltd. (BHP) announced plans to proceed with its Jansen Mine Project in Saskatchewan, Canada, potentially tapping the largest and longest-lasting supply in the world known at this time. Scotiabank (BNS) recently commented on Jansen, stating that the added supply "could add the equivalent of 18%-20% of the potash market over recent years." Nearly all of the companies mentioned have had a pretty predictable mix of upgrades and downgrades. That's what makes a market.

  • [By Mark Hulbert]

    The stocks are C.H. Robinson Worldwide (CHRW) �, a freight-transportation company; chip maker Cirrus Logic (CRUS) �; independent oil company Forest Oil (FST) �; investment bank Greenhill & Co. (GHL) �; Intrepid Potash (IPI) �, a fertilizer company; retailer J.C. Penney (JCP) �; Quest Diagnostics (DGX) �, a medical diagnostic company; Strayer Education (STRA) �, a for-profit college; Tower Group International (TWGP) �, an insurance company; and Windstream Holdings (WIN) �, a rural telecommunications firm.

Hot Healthcare Equipment Stocks To Own For 2014: Affymetrix Inc.(AFFX)

Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets primarily in the United States, Europe, Japan. The company provides integrated GeneChip microarray platform, which includes disposable DNA probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. It also offers GeneTitan, an instrument system that runs genotyping and gene expression array plates; and GeneAtlas, an instrument for low-to-medium throughput that provides hybridization and array processing with microwell-based labware, as well as a line of multiplex assays to serve the discovery and the validation markets. In addition, the company provides reagent kits, including ExoSAP-IT fo r a reagent for the clean-up of polymerase chain reaction (PCR) products used in downstream applications, such as DNA sequencing or single-nucleotide polymorphisms analysis; and HotStart-IT reagents that utilize a novel primer binding protein to inhibit primer dimer formation with results in sensitive and consistent amplification for PCR. Its products are used primarily in genotyping and gene expression applications. The company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies; academic research centers, government research laboratories, private foundation laboratories, and clinical reference laboratories in North America and Europe, as well as through life science supply specialists acting as authorized distributors in Latin America, the Middle East, and Asia Pacific regions. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.

Advisors' Opinion:
  • [By Alex Planes]

    However, Fool biotech expert Brian Orelli points out one big caveat: Once sequencing companies make these tests accessible, margins may collapse beyond the ability of volume sales to make up the difference. At least Illumina (and Life Tech) are in the driver's seat on margins, as it's unlikely that lesser-funded sequencing competitors Affymetrix (NASDAQ: AFFX  ) and Pacific Biosciences (NASDAQ: PACB  ) can muster the resources to push out sequencing at cost-effective scale before their peers.

  • [By Monica Gerson]

    Breaking news

    Acceleron Pharma (NASDAQ: XLRN) today announced that it has commenced an underwritten public offering of $100 million of its common stock. To read the full news, click here. XenoPort (NASDAQ: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering. To read the full news, click here. Affymetrix (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan庐 Dx Assay. To read the full news, click here. Verizon Communications (NYSE: VZ) and Intel (NASDAQ: INTC) today announced an agreement for Verizon to purchase from Intel the assets of Intel Media, a business division dedicated to the development of Cloud TV products and services. To read the full news, click here.

    Posted-In: Evercore Partners US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Hot Healthcare Equipment Stocks To Own For 2014: AptarGroup Inc. (ATR)

AptarGroup, Inc. engages in the design, development, manufacture, and sale of consumer product dispensing systems in North America, Europe, Asia, and South America. The company operates in three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, and accessories to the personal care and household markets, as well as pumps and decorative components to the fragrance/cosmetic market; and fragrance/cosmetic and personal care fine mist spray pumps, personal care lotion pumps, and continuous spray aerosol valves. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments in pharmaceutical market. The Food + Beverage segment offers dispensing and non-dispensing closures, spray pumps, and aerosol valves to the food and beverage markets. AptarGroup, Inc. sells its products through sales force, independent representatives, and distributors. The c ompany was founded in 1992 and is headquartered in Crystal Lake, Illinois.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on AptarGroup (NYSE: ATR  ) , whose recent revenue and earnings are plotted below.

Hot Healthcare Equipment Stocks To Own For 2014: Synovus Financial Corp.(SNV)

Synovus Financial Corp., a diversified financial services and bank holding company, provides commercial and retail banking, financial management, insurance, and mortgage services in Georgia, Alabama, South Carolina, Florida, and Tennessee. Its retail banking services include accepting customary types of demand and savings deposits; mortgage, installment, and other retail loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet based banking services; and bank credit card services, including mastercard and visa services. The company?s commercial banking services comprise cash management and asset management services, capital markets services, and institutional trust services, as well as commercial, financial, and real estate loans. It also provides various other financial services, which include the portfolio management for fixed-income securities, investment banking, the execution of securities transac tions as a broker/dealer, and the provision of individual investment advice on equity and other securities; trust services; mortgage services; and financial planning services. Synovus Financial Corp. was founded in 1888 and is headquartered in Columbus, Georgia.

Advisors' Opinion:
  • [By Selena Maranjian]

    Caxton Associates reduced its stake in lots of companies, including Georgia-based Synovus Financial (NYSE: SNV  ) . Synovus has been posting strong return-on-equity (ROE) numbers. In May, it acquired $54 million in deposits from the failed Sunrise Bank. Bears worry about the bank's significant residential real estate business and the current low interest rate environment. It has also been working to pay off its TARP obligations.

Hot Healthcare Equipment Stocks To Own For 2014: Lynas Corp Ltd (LYSDY)

Lynas Corporation Limited is engaged in integrated extraction and processing of rare earth minerals, primarily in Australia and Malaysia; and development of Rare Earth deposits. The Company is engaged in commercial production and shipments of Rare Earths products. The Company has Temporary Operating Licence (TOL) for its Lynas Advanced Materials Plant (LAMP). The Company�� subsidiary includes Lynas Malaysia Sdn Bdh, Lynas Services Pty Ltd, Mount Weld Holdings Pty Ltd, Mount Weld Mining Pty Ltd, Lynas Africa Holdings Pty Ltd and Lynas Africa Ltd. Lynas Malaysia Sdn Bdh operates and develops advanced material processing plant. Mount Weld Mining Pty Ltd is engaged in development of mining areas of interest and operation of concentration plant. Lynas Africa Ltd is engaged in mineral exploration. Advisors' Opinion:
  • [By Rich Duprey]

    Molycorp also needs to contend with the fact that there's a limited market for the metals it will mine at the same time�Lynas (NASDAQOTH: LYSDY  ) is�already out there producing them in Malaysia, let alone what China itself is bringing to the market. To think it can substantially crack the market at a profitable price in sufficient quantities, even if it does become a low (or the lowest) cost producer, is wishful thinking of the highest order.

No comments:

Post a Comment